T-CELLS AND MONOCYTES REGULATE THE GENERATION AND FUNCTIONAL-ACTIVITY OF NATURAL KILLER-DERIVED LYMPHOKINE-ACTIVATED KILLER-CELLS

被引:1
作者
ATZPODIEN, J [1 ]
GULATI, SC [1 ]
机构
[1] MEM SLOAN KETTERING CANC CTR, DEPT MED, NEW YORK, NY 10021 USA
关键词
LAK CELLS; NK REGULATION; T-CELLS;
D O I
10.1002/stem.5530110620
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The lymphokine-activated killer (LAK) phenomenon is generally referred to as nonspecific, i.e., major histocompatibility complex (MHC)-unrestricted cytotoxicity against tumor cells generated by ex vivo culture of human peripheral blood lymphocytes with interleukin 2 (IL-2). In this study, we selectively purified and depleted cell subpopulations such as natural killer (NK) cells, T-lymphocytes and monocytes from fresh human peripheral blood by negative selection. While highly purified NK cells could be induced to acquire potent LAK activity in five-day culture with IL-2, the presence of T-lymphocytes and monocytes in NK cultures was needed in order to induce a significant expansion of cytotoxic effector cells over the culture period. Neither T cells nor monocytes by themselves were able to generate LAK cells in a standard rive-day IL-2 culture. However, when added to highly purified NK cells prior to IL-2 incubation, a proportion of CD3, T-lymphocytes was found to gain LAK-like killing activity. Monocytes, when cultured with IL-2 in the presence of NK cells and T-lymphocytes, did not appear to acquire LAK activity but were able to induce a dramatic increase in cytotoxic lymphocyte recovery after five days with IL-2. In summary, we could demonstrate that peripheral blood T-lymphocytes and monocytes are potent regulators of NK-dependent lymphokine (IL-2)-activated killing.
引用
收藏
页码:511 / 518
页数:8
相关论文
共 36 条
[1]  
ATZPODIEN J, 1987, NAT IMMUN CELL GROW, V6, P129
[2]   EWING SARCOMA - EXVIVO SENSITIVITY TOWARDS NATURAL AND LYMPHOKINE-ACTIVATED KILLING [J].
ATZPODIEN, J ;
GULATI, SC ;
SHIMAZAKI, C ;
BUHRER, C ;
OZ, S ;
KWON, JH ;
KOLITZ, JE ;
CLARKSON, BD .
ONCOLOGY, 1988, 45 (06) :437-443
[3]   HOME THERAPY WITH RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN ADVANCED HUMAN MALIGNANCIES [J].
ATZPODIEN, J ;
KORFER, A ;
FRANKS, CR ;
POLIWODA, H ;
KIRCHNER, H .
LANCET, 1990, 335 (8704) :1509-1512
[4]  
ATZPODIEN J, 1990, MOL BIOTHER, V2, P1
[5]   IMPROVED QUANTIFICATION OF CELLULAR CYTO-TOXICITY REACTIONS - DETERMINATION OF KINETIC-PARAMETERS FOR NATURAL CYTO-TOXICITY BY A DISTRIBUTION-FREE PROCEDURE [J].
CALLEWAERT, DM ;
SMEEKENS, SP ;
MAHLE, NH .
JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 49 (01) :25-37
[6]   CHROMIC CHLORIDE METHOD OF COUPLING ANTIGENS TO ERYTHROCYTES - DEFINITION OF SOME IMPORTANT PARAMETERS [J].
GODING, JW .
JOURNAL OF IMMUNOLOGICAL METHODS, 1976, 10 (01) :61-66
[7]   FUNCTIONAL-STUDIES ON THE PRECURSORS OF HUMAN LYMPHOKINE-ACTIVATED KILLER CELLS [J].
GRAY, JD ;
SHAU, HY ;
GOLUB, SH .
CELLULAR IMMUNOLOGY, 1985, 96 (02) :338-350
[8]   EXPRESSION OF MYELOID DIFFERENTIATION ANTIGENS ON NORMAL AND MALIGNANT MYELOID CELLS [J].
GRIFFIN, JD ;
RITZ, J ;
NADLER, LM ;
SCHLOSSMAN, SF .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) :932-941
[9]  
GRIFFIN JD, 1983, J IMMUNOL, V130, P2947
[10]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
GRIMM, EA ;
MAZUMDER, A ;
ZHANG, HZ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841